Alexion Pharmaceuticals Inc $167.04

down -0.44


25/7/2014 04:00 PM  |  NASDAQ : ALXN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ALXN Trend Analysis - it has outperformed the S&P 500 by 38%

Partner Headlines

  1. Biotechs Fall Despite Beats

    IBD
  2. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  3. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  4. Stocks Up And Down At Open; Under Armour, Facebook Surge

    IBD
  5. US Stock Futures Gain Ahead Of Earnings, Economic Data

    Benzinga
  6. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  7. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  8. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  9. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  10. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  11. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  12. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  13. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  14. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  15. Will New Drug Give Alexion Pharmaceuticals A Boost?

    IBD
  16. Inside The IBD 50: Leaders Show Mixed Action

    IBD
  17. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  18. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  19. Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As ...

    Benzinga
  20. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  21. 4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

    Benzinga
  22. Stocks Mixed As Losses Pared; Foot Locker Steps Up

    IBD
  23. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  24. Techs, Small Cap Stocks Lead; Family Dollar Heads Group Rally

    IBD
  25. After The Biotech Sell-off, How Will Investors Treat Alexion Pharmaceuticals?

    IBD
  26. Alexion, Priceline, OpenTable: A Top Manager's View

    IBD
  27. Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices ...

    Benzinga
  28. US Stock Futures Decline After China Data

    Benzinga
  29. Earnings Growth Anemic But Medical Sector Healthy

    IBD
  30. Kors Among 5 Stocks With Superior 3-Year EPS Growth

    IBD
  31. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  32. Alexion Tops, Celgene Mixed

    IBD
  33. Stocks Mixed In Late Trade; Goodyear Breaks Out

    IBD
  34. Nasdaq Leads As Indexes Reverse Upward

    IBD
  35. Alexion, Celgene Report Contrasting Q1 Earnings

    IBD
  36. US Stock Futures Surge After Upbeat Apple Earnings

    Benzinga
  37. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga
  38. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  39. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  40. Facebook, Walgreen Climb Monday On International News

    IBD
  41. IPO Frenzy Freezes As 4 New Issues Delayed

    IBD
  42. Stocks Fall In Higher Volume; Alexion, Gilead Drop 7%

    IBD
  43. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  44. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  45. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  46. Nasdaq Sheds 1% As China Growth Names, Biotechs Fall Hard

    IBD
  47. S&P 500 Edges Lower As Biotech Selling Weighs On Nasdaq

    IBD
  48. Nasdaq Leads Another Up Day; S&P 500 Hits All-Time High

    IBD
  49. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  50. Gilead Adds To Biotech Woes

    IBD
Trading Center